| Literature DB >> 25767724 |
Vladimir O Pustylnyak1, Pavel D Lisachev2, Mark B Shtark3.
Abstract
Gene expression plays an important role in the mechanisms of long-term potentiation (LTP), which is a widely accepted experimental model of synaptic plasticity. We have studied the expression of at least 50 genes that are transcriptionally regulated by p53, as well as other genes that are related to p53-dependent processes, in the early phase of LTP. Within 30 min after Schaffer collaterals (SC) tetanization, increases in the mRNA and protein levels of Bax, which are upregulated by p53, and a decrease in the mRNA and protein levels of Bcl2, which are downregulated by p53, were observed. The inhibition of Mdm2 by nutlin-3 increased the basal p53 protein level and rescued its tetanization-induced depletion, which suggested the involvement of Mdm2 in the control over p53 during LTP. Furthermore, nutlin-3 caused an increase in the basal expression of Bax and a decrease in the basal expression of Bcl2, whereas tetanization-induced changes in their expression were occluded. These results support the hypothesis that p53 may be involved in transcriptional regulation during the early phase of LTP. We hope that the presented data may aid in the understanding of the contribution of p53 and related genes in the processes that are associated with synaptic plasticity.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25767724 PMCID: PMC4341845 DOI: 10.1155/2015/242158
Source DB: PubMed Journal: Neural Plast ISSN: 1687-5443 Impact factor: 3.599
Expression of p53-related genes in rat hippocampal CA1 area 30 min after tetanization.
| Symbol | p53 transcriptional target genes | Vehicle | Nutlin-3 | |||||
|---|---|---|---|---|---|---|---|---|
| Tetanization-induced fold change | Basal expression fold change | Tetanization-induced fold change | ||||||
| Regulation | Reference | TSv/CSv | Paired | CSn/CSv |
| TSn/CSn | Paired | |
| Apaf1 | + | [ | 1,25 | ∗ | 1,25 | ∗ | 1,25 | ∗ |
|
| 1,11 | ∗ | 1,29 | ∗ | 0,98 | ns | ||
| Atm | 1,27 | ∗ | 1,37 | ∗ | 1,08 | ∗ | ||
|
| 1,13 | ∗ | 1,30 | ∗ | 1,01 | ns | ||
|
| + | [ | 1,41 | ∗ | 1,38 | ∗ | 1,08 | ns |
| Bbc3 | + | [ | 0,93 | ∗ | 1,33 | ∗ | 0,87 | ∗ |
|
| − | [ | 0,71 | ∗ | 0,92 | ∗ | 0,94 | ns |
| Bid | + | [ | 1,26 | ∗ | 1,23 | ∗ | 1,19 | ∗ |
| Birc5 | − | [ | 1,22 | ns | 1,35 | ∗ | 1,08 | ns |
| Bnip3 | 1,13 | ∗ | 1,27 | ∗ | 1,08 | ∗ | ||
| Brca1 | − | [ | 1,38 | ∗ | 1,58 | ∗ | 1,51 | ns |
| Brca2 | 1,20 | ∗ | 1,10 | ∗ | 1,51 | ∗ | ||
| Btg2 | + | [ | 1,47 | ∗ | 1,41 | ∗ | 1,11 | ∗ |
| Casp2 | 1,30 | ∗ | 1,34 | ∗ | 1,12 | ∗ | ||
|
| 1,14 | ∗ | 1,28 | ∗ | 1,02 | ns | ||
| Ccnb1 | − | [ | 1,03 | ns | 1,12 | ∗ | 1,18 | ∗ |
|
| 1,26 | ∗ | 1,31 | ∗ | 1,10 | ns | ||
| Ccng1 | + | [ | 1,31 | ∗ | 1,35 | ∗ | 1,16 | ∗ |
| Ccnh | 1,18 | ∗ | 1,25 | ∗ | 1,11 | ∗ | ||
| Cdc25a | − | [ | 1,09 | ns | 1,06 | ns | 1,31 | ∗ |
| Cdc25c | − | [ | 1,17 | ns | 1,13 | ∗ | 1,27 | ∗ |
| Cdk1 | − | [ | 0,96 | ns | 1,01 | ns | 1,31 | ∗ |
| Cdk4 | 1,10 | ∗ | 1,24 | ∗ | 1,07 | ∗ | ||
|
| + | [ | 1,20 | ∗ | 1,17 | ∗ | 1,15 | ns |
| Cdkn2a | − | [ | 1,06 | ns | 1,38 | ∗ | 1,19 | ns |
|
| − | [ | 1,31 | ∗ | 1,29 | ∗ | 1,07 | ns |
| Chek2 | − | [ | 1,04 | ns | 1,22 | ns | 1,18 | ∗ |
| Cul9 | 1,20 | ns | 1,35 | ∗ | 1,05 | ns | ||
| Dapk1 | + | [ | 1,34 | ∗ | 1,41 | ∗ | 0,90 | ∗ |
| Dnmt1 |
| [ | 1,15 | ns | 1,19 | ns | 1,16 | ∗ |
| E2f1 | − | [ | 1,34 | ∗ | 1,22 | ∗ | 1,28 | ∗ |
| E2f3 | 1,62 | ∗ | 1,78 | ∗ | 0,76 | ∗ | ||
| Egfr | + | [ | 1,39 | ∗ | 1,33 | ∗ | 1,29 | ∗ |
| Egr1 | + | [ | 1,22 | ∗ | 1,21 | ∗ | 1,11 | ∗ |
|
| 1,17 | ∗ | 1,22 | ∗ | 1,02 | ns | ||
| Ercc1 | 1,17 | ∗ | 1,29 | ∗ | 1,11 | ∗ | ||
| Fadd | 1,39 | ∗ | 1,57 | ∗ | 0,83 | ∗ | ||
| Fas | + | [ | 1,18 | ns | 1,14 | ∗ | 1,23 | ns |
| Faslg | + | [ | 1,19 | ns | 1,19 | ∗ | 1,14 | ∗ |
| Foxo3 | 1,49 | ∗ | 1,69 | ∗ | 0,79 | ∗ | ||
|
| + | [ | 1,26 | ∗ | 1,41 | ∗ | 0,96 | ns |
| Hdac1 | 1,12 | ns | 1,24 | ∗ | 1,10 | ns | ||
|
| 1,30 | ∗ | 1,46 | ∗ | 0,95 | ns | ||
| Igf1r | 1,08 | ns | 1,14 | ∗ | 1,11 | ∗ | ||
| Il6 | − | [ | 1,45 | ∗ | 1,31 | ∗ | 1,26 | ∗ |
| Jun | 1,35 | ∗ | 1,32 | ∗ | 1,15 | ∗ | ||
| Kras | 1,11 | ns | 1,22 | ∗ | 1,07 | ns | ||
| Mcl1 | 1,30 | ∗ | 1,32 | ∗ | 1,12 | ∗ | ||
|
| + | [ | 1,21 | ∗ | 1,22 | ∗ | 1,13 | ns |
| Mdm4 | 1,16 | ns | 1,27 | ∗ | 1,03 | ns | ||
| Mlh1 |
| [ | 1,16 | ns | 1,21 | ∗ | 1,06 | ns |
| Msh2 | + | [ | 1,10 | ns | 1,11 | ns | 1,16 | ∗ |
| Myc | − | [ | 1,48 | ∗ | 1,31 | ∗ | 1,34 | ∗ |
| Nf1 | 1,54 | ∗ | 1,25 | ∗ | 1,37 | ∗ | ||
| Nfkb1 | 1,27 | ∗ | 1,27 | ∗ | 1,12 | ∗ | ||
| Pcna |
| [ | 1,33 | ∗ | 1,28 | ∗ | 1,29 | ∗ |
| Pmaip1 | + | [ | 1,55 | ∗ | 1,47 | ∗ | 1,16 | ∗ |
| Ppm1d | + | [ | 1,11 | ∗ | 1,23 | ∗ | 1,10 | ∗ |
| Prc1 | − | [ | 1,29 | ns | 1,28 | ∗ | 1,20 | ns |
| Prkca | − | [ | 1,30 | ∗ | 0,92 | ∗ | 1,58 | ∗ |
|
| + | [ | 1,47 | ∗ | 1,46 | ∗ | 0,92 | ns |
| Pttg1 | − | [ | 0,89 | ∗ | 0,96 | ns | 0,69 | ∗ |
| Rb1 | − | [ | 1,16 | ns | 1,30 | ∗ | 1,01 | ns |
|
| 1,18 | ∗ | 1,31 | ∗ | 0,99 | ns | ||
| RGD1566319 | + | [ | 1,23 | ns | 1,32 | ∗ | 1,04 | ns |
| Rprm | + | [ | 0,74 | ∗ | 0,95 | ns | 1,15 | ∗ |
| S100B | + | [ | 2,93 | ∗ | 1,51 | ∗ | 1,88 | ∗ |
| Sirt1 | 1,46 | ∗ | 1,32 | ∗ | 1,22 | ∗ | ||
|
| 1,24 | ∗ | 1,36 | ∗ | 1,00 | ns | ||
| Tnf | + | [ | 1,28 | ∗ | 1,25 | ∗ | 1,13 | ∗ |
| Tp53 | + | [ | 1,00 | ns | 1,17 | ns | 1,07 | ∗ |
|
| − | [ | 1,11 | ∗ | 1,13 | ∗ | 1,06 | ns |
| Tp63 |
| [ | 1,17 | ns | 0,98 | ns | 1,39 | ∗ |
| Tp73 | + | [ | 2,15 | ∗ | 1,43 | ∗ | 1,76 | ∗ |
| Xrcc4 | 1,03 | ns | 1,14 | ∗ | 1,15 | ∗ | ||
| Xrcc5 | 1,35 | ns | 1,40 | ∗ | 1,10 | ns | ||
| Zmat3 | + | [ | 0,99 | ns | 1,06 | ns | 1,22 | ∗ |
TSv, CSv, TSn, CSn: test and control samples from experiments with vehicle (DMSO 0.1%) or nutlin-3 (20 μM). Tetanization-induced fold changes (TSv/CSv and TSn/CSn) were expressed by taking the value of the corresponding control as one. Basal expression fold change (CSn/CSv) was expressed by taking average value of the group CSv as one. Italic marks symbols of the genes, which are regulated similarly by tetanization and nutlin, and effect of tetanization is occluded by nutlin. * P < 0.05 (n = 4), ns: not significant.
Figure 1Long-term potentiation in the rat hippocampal CA1 area. (a) Representative responses to test stimuli before tetanization (left) and 30 min after tetanization (right). Calibration bars: 3 ms, 1 mV. (b, c) Abscissa, the time from the onset of tetanization. Ordinate, the amplitude of p-spikes (b) or the slope of field excitatory postsynaptic potentials (c), which is normalized to the amplitude of the response to the stimulus that immediately preceded tetanization. The data are the mean ± S.E.M. (n = 4).
Description of p53-related genes.
| RefSeq | Symbol | Description | Gene name |
|---|---|---|---|
| NM_023979 | Apaf1 | Apoptotic peptidase activating factor 1 | — |
| NM_024148 | Apex1 | APEX nuclease (multifunctional DNA repair enzyme) 1 | APE, Apex, REF-1 |
| NM_001106821 | Atm | Ataxia telangiectasia mutated homolog (human) | — |
| NM_001106647 | Bag1 | BCL2-associated athanogene | — |
| NM_017059 | Bax | Bcl2-associated X protein | — |
| NM_173837 | Bbc3 | Bcl-2 binding component 3 | Puma |
| NM_016993 | Bcl2 | B-cell CLL/lymphoma 2 | Bcl-2 |
| NM_022684 | Bid | BH3 interacting domain death agonist | — |
| NM_022274 | Birc5 | Baculoviral IAP repeat-containing 5 | AP14 |
| NM_053420 | Bnip3 | BCL2/adenovirus E1B interacting protein 3 | MGC93043 |
| NM_012514 | Brca1 | Breast cancer 1 | — |
| NM_031542 | Brca2 | Breast cancer 2 | — |
| NM_017259 | Btg2 | BTG family, member 2 | Agl, An, Pc3, Tis21, an-1 |
| NM_022522 | Casp2 | Caspase 2 | — |
| NM_031632 | Casp9 | Caspase 9, apoptosis-related cysteine peptidase | Apaf3, Casp-9-CTD, Casp9_v1, Ice-Lap6, Mch6 |
| NM_171991 | Ccnb1 | Cyclin B1 | — |
| NM_001100821 | Ccne1 | Cyclin E1 | CYCLE, Ccne |
| NM_012923 | Ccng1 | Cyclin G1 | CYCG, Ccng, MGC93642 |
| NM_052981 | Ccnh | Cyclin H | — |
| NM_133571 | Cdc25a | Cell division cycle 25 homolog A ( | — |
| NM_001107396 | Cdc25c | Cell division cycle 25 homolog C ( | — |
| NM_019296 | Cdk1 | Cyclin-dependent kinase 1 | Cdc2, Cdc2a |
| NM_053593 | Cdk4 | Cyclin-dependent kinase 4 | — |
| NM_080782 | Cdkn1a | Cyclin-dependent kinase inhibitor 1A | Cip1, Waf1 |
| NM_031550 | Cdkn2a | Cyclin-dependent kinase inhibitor 2A | Arf, INK4A, MTS1, p16, p16Cdkn2a, p19ARF |
| NM_080400 | Chek1 | CHK1 checkpoint homolog ( | — |
| NM_053677 | Chek2 | CHK2 checkpoint homolog ( | Chk2, Rad53 |
| XM_236927 | Cul9 | Cullin 9 | Parc, RGD1562008 |
| NM_001107335 | Dapk1 | Death associated protein kinase 1 | — |
| NM_053354 | Dnmt1 | DNA (cytosine-5-)-methyltransferase 1 | — |
| NM_001100778 | E2f1 | E2F transcription factor 1 | — |
| NM_001137626 | E2f3 | E2F transcription factor 3 | RGD1561600 |
| NM_031507 | Egfr | Epidermal growth factor receptor | ERBB1, ErbB-1, Errp |
| NM_012551 | Egr1 | Early growth response 1 | Krox-24, NGFI-A, Ngf1, Ngfi, zif-268 |
| XM_576312 | Ep300 | E1A binding protein p300 | — |
| NM_001106228 | Ercc1 | Excision repair cross-complementing rodent repair deficiency, complementation group 1 | — |
| NM_012689 | Esr1 | Estrogen receptor 1 | ER-alpha, Esr, RNESTROR |
| NM_152937 | Fadd | Fas (TNFRSF6) associated via death domain | Mort1 |
| NM_139194 | Fas | Fas (TNF receptor superfamily, member 6) | Tnfrsf6 |
| NM_012908 | Faslg | Fas ligand (TNF superfamily, member 6) | Apt1Lg1, CD95-L, Fasl, Tnfsf6 |
| NM_001106395 | Foxo3 | Forkhead box O3 | Fkhrl1, Foxo3a |
| NM_024127 | Gadd45a | Growth arrest and DNA-damage-inducible, alpha | Ddit1, Gadd45 |
| NM_001025409 | Hdac1 | Histone deacetylase 1 | — |
| NM_024359 | Hif1a | Hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | MOP1 |
| NM_052807 | Igf1r | Insulin-like growth factor 1 receptor | IGFIRC, JTK13 |
| NM_012589 | Il6 | Interleukin 6 | ILg6, Ifnb2 |
| NM_021835 | Jun | Jun oncogene | — |
| NM_031515 | Kras | V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | Kras2, c-Ki-ras, p21 |
| NM_001106095 | Lig4 | Ligase IV, DNA, ATP-dependent | — |
| XM_346005 | LOC367198 | Similar to Serine/threonine-protein kinase ATR (Ataxia telangiectasia and Rad3-related protein) | — |
| NM_021846 | Mcl1 | Myeloid cell leukemia sequence 1 | — |
| NM_001108099 | Mdm2 | Mdm2 p53 binding protein homolog (mouse) | — |
| NM_001012026 | Mdm4 | Mdm4 p53 binding protein homolog (mouse) | — |
| NM_031053 | Mlh1 | MutL homolog 1 ( | — |
| NM_031058 | Msh2 | MutS homolog 2 ( | — |
| NM_012603 | Myc | Myelocytomatosis oncogene | MGC105490, RNCMYC, c-myc, mMyc |
| NM_176079 | Myod1 | Myogenic differentiation 1 | MGC156574 |
| NM_012609 | Nf1 | Neurofibromin 1 | — |
| XM_342346 | Nfkb1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | NF-kB |
| NM_022381 | Pcna | Proliferating cell nuclear antigen | PCNAR, Pcna, cyclin |
| NM_001008385 | Pmaip1 | Phorbol-12-myristate-13-acetate-induced protein 1 | Noxa |
| NM_001105825 | Ppm1d | Protein phosphatase 1D magnesium-dependent, delta isoform | — |
| NM_001107529 | Prc1 | Protein regulator of cytokinesis 1 | — |
| NM_001105713 | Prkca | Protein kinase C, alpha | Pkca |
| NM_031606 | Pten | Phosphatase and tensin homolog | MMAC1, Mmac, TEP1 |
| NM_022391 | Pttg1 | Pituitary tumor-transforming 1 | Pttg |
| NM_017045 | Rb1 | Retinoblastoma 1 | — |
| NM_199267 | Rela | V-rel reticuloendotheliosis viral oncogene homolog A (avian) | NFkB |
| NM_001109358 | RGD1566319 | Similar to Sestrin 2 (Hi95) | — |
| NM_001044276 | Rprm | Reprimo, TP53 dependent G2 arrest mediator candidate | MGC109515 |
| NM_013191 | S100B | S100 calcium binding protein B | — |
| NM_057108 | Serpinb5 | Serpin peptidase inhibitor, clade B (ovalbumin), member 5 | Maspin, PI-5, Pi5 |
| XM_232745 | Sfn | Stratifin | — |
| NM_001107627 | Sirt1 | Sirtuin (silent mating type information regulation 2 homolog) 1 ( | Sir2 |
| NM_032612 | Stat1 | Signal transducer and activator of transcription 1 | — |
| NM_012675 | Tnf | Tumor necrosis factor (TNF superfamily, member 2) | MGC124630, RATTNF, TNF-alpha, Tnfa |
| NM_001108873 | Tnfrsf10b | Tumor necrosis factor receptor superfamily, member 10b | — |
| NM_030989 | Tp53 | Tumor protein p53 | MGC112612, Trp53, p53 |
| XM_223012 | Tp53bp2 | Tumor protein p53 binding protein, 2 | Trp53bp2 |
| NM_019221 | Tp63 | Tumor protein p63 | Ket, P73l, Tp73l, Trp63 |
| NM_001108696 | Tp73 | Tumor protein p73 | P73, Trp73 |
| NM_031534 | Wt1 | Wilms tumor 1 | — |
| NM_001006999 | Xrcc4 | X-ray repair complementing defective repair in Chinese hamster cells 4 | MGC95022 |
| NM_177419 | Xrcc5 | X-ray repair complementing defective repair in Chinese hamster cells 5 | Ku80, Kup80 |
| NM_022548 | Zmat3 | Zinc finger, matrin type 3 | PAG608, Wig1 |
Figure 2Effect of tetanization on p53, Bax, and Bcl2 in the rat hippocampal CA1 area. (a) Total RNAs were prepared and subjected to real-time PCR for the measurement of mRNAs. The mean of Ct values of five housekeeping genes was used as internal control for normalization as described in Section 2. (b) Representative Western blots. Whole-cell extracts were prepared from the rat hippocampal CA1 area and subjected to Western blot analysis as described in Section 2. (c) Relative intensity. The protein bands were analyzed by the computerized densitometric program “Total Lab.” The intensities of the signals were determined from the areas under the curves for each peak and data were graphed. β-actin was used as internal control for normalization. The fold changes were expressed by taking the average value of the group tetanization(−)/nutlin-3(−) as one. * P < 0.05 against corresponding tetanization(−) samples (paired t-test), # P < 0.05 against the group tetanization(−)/nutlin-3(−) (t-test), n = 4.